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ABSTRACT
Insulin was first identified as an anabolic pancreatic hormone responsible for
glucose homeostasis, and Insulin-like Growth Factor (IGF-I) as the mediator of the
action of Growth Hormone on postnatal growth. New molecular, pharmacological
and embryological information has broadened the scope of the physiological roles
of these hormones and their related molecules, particularly the insulin precursor
proinsulin, during vertebrate development. Studies in our laboratory have
demonstrated that proinsulin is expressed and functional before emergence of the
pancreas. Proinsulin gene expression in the chick and mouse embryo shows fine
transcriptional and postrancriptional regulation with generation of specific
embryonic transcripts which are differentially translated. The protein product
remains as unprocessed proinsulin that protects the cells from excessive apoptosis
during neurulation. In contrast, IGF-I is expressed later than proinsulin in the
chick embryo and it starts in the nervous system. In the mouse embryo, generation
of olfactory bulb stem cells in culture has allowed the study of these molecules’
role in the proliferation and differentiation of neural precursors. Proinsulin and
IGF-I can cooperate with mitogens (EGF and FGF2) in the control of stem/
precursor cells proliferation and IGF-I is an essential factor for neural
differentiation. Mice deficient in IGF-I present a disruption of olfactory bulb
cytoarchitecture, with decreased numbers of mitral cells and abnormal radial glia.
This article gives thus an overview of the important role of insulin family proteins
in development.
* Toma de Posesión como Académica Correspondiente, 4 de noviembre de 2004.
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RESUMEN
Hormonas tradicionales de la familia de la insulina como nuevas señales
en el desarrollo
La insulina fue identificada como una hormona anabólica pancreática,
responsable de la homeostasis de la glucosa, y el Factor de Crecimiento similar a
la Insulina tipo I (IGF-I) como el mediador de la acción de la Hormona de
Crecimiento postnatalmente. Nuevas informaciones moleculares, farmacológicas y
embriológicas han ampliado el concepto del papel fisiológico de estas hormonas
y sus moléculas relacionadas, particularmente del precursor de la insulina, la
proinsulina, en el desarrollo de vertebrados. Los estudios de nuestro laborato-
rio han demostrado que la proinsulina está expresada y es funcional antes de
que aparezca el páncreas. La expresión de proinsulina en los embriones de pollo
y ratón muestra regulación transcripcional y post-transcripcional muy fina, con
la generación de transcritos específicos embrionarios que se traducen de for-
mas distintas. El producto de estos mRNAs se mantiene como proinsulina sin
procesar, que protege a las células de la apoptosis excesiva durante la neurulación.
En contraste, el IGF-I está expresado más tarde que la proinsulina en el embrión
de pollo y comienza en el sistema nervioso. En el embrión de ratón, la generación
de células madre neurales en cultivo ha permitido estudiar el papel de estas
moléculas en la proliferación y diferenciación de precursores neurales. La
proinsulina y el IGF-I pueden cooperar con los mitógenos (EGF y FGF2) en el
control de la proliferación de células madre/precursores mientras que el IGF-I es
un factor esencial para la diferenciación neural. Los ratones deficientes en IGF-I
presentan alteración de la citoarquitectura del bulbo olfatorio con disminución del
número de neuronas mitrales y glía radial anormal. Este artículo da una visión
global del importante papel de las proteínas de la familia de la insulina en el
desarrollo.
Palabras clave: Proinsulina.—Factor de crecimiento similar a la insulina
tipo I.— Embrión.—Células madre.—Neurogénesis.
INTRODUCTION
We celebrate this year, 2005, the 100th anniversary of the birth
of Endocrinology as a discipline, marked by the introduction of
the term «hormone» by Ernest Henry Starling. He proposed this
name to designate certain chemicals, elaborated by glands and
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transported to distant body parts through the bloodstream, modifying
body functions (38). In the following decades, the study of hormones
was thus parallel to the study of the so named endocrine glands,
thinking that they were fixed couples. With the speed of biological
discovery in the «omics» era (genomics, proteomics, metabolomics,
etc.), however, very few concepts have the label of dogma for very
long time.
Insulin, since it was discovered by Banting and Best in 1921 and
extracted from the dog pancreas (2), started a medical and
pharmaceutical revolution in the treatment of diabetics, and
remained known as an exclusive pancreatic hormone of vertebrates
for most of the 20th century. With the advance of molecular and
cellular techniques in recent years, it has become evident that insulin
and its precursor proinsulin are expressed prior to pancreatic
development and in organisms without a pancreas. In essence, all
multicellular organisms are thought to have ancestral or evolved
protein(s) of the insulin family (6) whereas the yeast genome does
not contain any similar protein (8). The protochordate Amphioxus
contains a single proinsulin-like gene (7) and more recent
acquisitions led to the appearance of insulin-like growth factor (IGF)
I and II in fish, amphibians and birds (6). In humans, there is
an extended insulin family of proteins including relaxin, placentin
and Leydig insulin-like peptide (21). These peptides signal the cells
binding to several types of membrane tyrosine kinase receptors,
from the ancestral single insulin receptor found in Amphioxus (30),
to the mammalian diversified forms. These include the two forms of
insulin receptor, containing or skiping exon 11 (4), the IGF-I receptor
(15) and the hybrid receptors generated by them (17,29).
Autophosphorylation of tyrosine residues in the ß-subunit of these
receptors leads to phosphorylation in insulin receptor substrates
(IRS) 1 to 4 and other transduction molecules (26,34), activating two
major intracellular pathways: the PI3-kinase/Akt and the Ras/MAPK
pathways (5,24). These signalling cascades and networks of activated
molecules influence multiple cellular processes, including proli-
feration, cell growth, differentiation, migration, metabolism, and
overall life span (16,20,33).
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FIGURE 1. A) Mosaic representing a chick embryo of approximately 3 days of deve-
lopment (E3) (Photography courtesy of Prof. Nicole Le Douarin. Institut d’Embriologie
Cellulaire et Moléculaire, Nogent-sur-Marne, France). B) and D) In situ hybridization
to demonstrate proinsulin mRNA distribution in the E1.5 and E2.5 chick embryo
respectively. The image is processed in pseudocolor, red indicates high signal. C) and
E) In situ hybridization for IGF-I mRNA at the indicated days of development (25).
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Expression of proinsulin and IGFs in chick embryo
gastrulation and neurulation
The chick embryo has been a classic vertebrate model to analyze
development from gastrulation, when the three embryo layers are
defined, to neurulation and early organogenesis. It is accessible and
indeed a beautiful artistic inspiration (Fig. 1A). Despite the lack
of a pancreatic rudiment morphologically until the third day of
incubation (E3), we found immunoreactive proinsulin/insulin in
extracts of E2 embryos by radioimmunoassay (11). The possibility of
quantifying the low amounts, as compared to pancreas, of embryonic
proinsulin mRNA was possible only by using large amounts of Poly-
A+ RNA, but confirmed the presence of transcripts in E2 chick
embryos (36). Surprisingly, even though IGF-I had been recognized as
a broadly expressed tissue growth factor, IGF-I mRNA was minimally
expressed prior to E3 in chick embryos, even when analyzed by the
highly sensitive technique of reverse transcription coupled to
polymerase chain reaction (RT-PCR) (37). Indeed, we could confirm
both by RT-PCR (31) and by in situ hybridization (Fig. 1) that during
neurulation proinsulin mRNA was broadly expressed along the
embryo whereas IGF-I was barely detectable (Fig. 1B, C) (25). In early
organogenesis, in E2.5 embryos, the expression of proinsulin mRNA
was more restricted, but still significant in developing brain, and
the two pancreatic buds (which will later be fused) were also positive
(Fig. 1D). IGF-I initial expression was mostly localized in cephalic
vesicles in E2.5 (Fig. 1E).
We were interested in defining if the protein produced by this
proinsulin transcript was unprocessed proinsulin or mature insulin
and for that purpose we developed an antiserum against the
connective C-peptide that is cleaved during processing of proinsulin
by the specific convertases. Immunofluorescence performed with this
antiserum confirmed the presence of proinsulin in distinct cells of
the three embryonic layers by E1. A few neuroepithelial cells were
the most clearly labelled (Fig. 2B). This was in contrast with the
absence of IGF-I in parallel sections (Fig. 2C), which agreed with the
previous RNA data. IGF-II was found in extracellular, likely basal
membrane, locations (Fig. 2D). With further development, in E2.5,
at mid embryo level, multiple structures expressed proinsulin,
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FIGURE 2. Distribution of factors by immunofluorescence in chick embryos. A-D) E1
embryos (stage 6), E-H) E2.5 embryos (stage 15). Transversal criosections at mid-
level in A, and caudal to the viteline artery in E (microscopy taken from Bellairs and
Osmond, The Atlas of Chick Development. 1998. San Diego, California, Academic
Press). Proinsulin is detected with an antipeptide-C antiserum (Rb40) in B (inset
shows a detail with labelled neuroectodermic cells in the lateral zone, arrowheads)
and F (positive areas include the floor plate of the neural tube, notochord and der-
mamyotome of somite). IGF-I immunostain is negative in C and labelled only a few
ectodermic (short arrow) and digestive endodermic cells (long arrows) in G. IGF-II
immunostain labelled basal membranes in D (arrow) and H (note around notochord
and neural tube). Fluorochorome was Cy2 and images were captured with a CCD
camera. ec, ectoderm; m, mesoderm; en, endoderm; n, notochord; ng, neural groove;
nt, neural tube; s, somite; fp, floor plate; dm, dermomyotome; st, sclerotome; de,
digestive endoderm; rm, renal mesenchyme; rt, renal tubule.
including the floor plate of the neural tube, notochord, dermomyoto-
me of the somite, and cells in the rudiment of the renal tubule and
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digestive endoderm (Fig. 2F). IGF-I protein was detected in a few
ectoderm cells in the dorsal part of the neural tube and a few cells
in the digestive endoderm (Fig. 2G). IGF-II was more broadly
present, decorating multiple basal membranes (Fig. 2H).
Overall, members of the insulin family are therefore present at
very early stages of vertebrate development, and the prohormone
proinsulin, previously believed to be nearly inactive, was expressed
in a tissue- and time-specific manner in the chick embryo. We had
proposed that there was an endocrinization of the early embryo (14),
but these hormone-like factors were there before circulation was
established, thus acting in more of a short-range, paracrine or
autocrine manner, rather than in the canonical endocrine, longe-
range form.
Embryonic proinsulin transcripts: more surprises
The multiple studies performed on pancreatic insulin regulation
aimed at understanding the physiopathology of diabetes and
approaches for therapy had demonstrated that glucose was the major
stimulus for proinsulin gene expression and insulin secretion (41).
Our studies with cultured prepancreatic chick embryos showed that
proinsulin mRNA at that stage was not regulated by glucose (31).
The analysis of the embryonic transcript provided further surprises,
since at least two different embryonic mRNAs were identified,
distinct from pancreatic proinsulin mRNA.
The chick embryo contains a single proinsulin gene, as in the
human, and in contrast to the mouse, in which the proinsulin gene
has been duplicated (see later). The protein coding region is
contained in exon 2 and exon 3, whereas exon 1 is untranslated
(5’UTR). The product obtained by rapid amplification of the cDNA
end (5’RACE) was different in the pancreas than in the E1.5 chick
embryo (Fig. 3).
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FIGURE 3. Schematic representation of different embryonic and pancreatic proinsulin
mRNA transcripts. Exons (e) and intron 1 (int) are represented. The arrow above
indicates the translation initiation site. The techniques used were 5’RACE and
RT-PCR with total RNA from pancreas and E1.5 chick embryos.
Exon 1 of the embryo had an extension of 32 nucleotides with
respect to exon 1 of the pancreas (19) yielding two mRNAs that we
termed Pro1B and Pro1A, respectively. The protein product in both
cases was proinsulin. Translation of the embryonic form is markedly
downregulated by the presence of two upstream AUGs within the 32
nucleotide extension of the Pro1B mRNA (19). A later approach using
PCR confirmed the expression from gastrulation to organogenesis
of the Pro1B transcript, and revealed another alternative proinsulin
transcript, a form that retained intron 1 (717 nucleotides) (28)
(Fig. 3). Termed Pro1B1, it is a mature cytoplasmic mRNA but its
translational capacity is nearly blocked due to its long leader region.
There was differential developmental regulation of this new mRNA,
with increasing abundance from gastrulation to neurulation and
organogenesis.
We wonder whether this highly sophisticated regulation of
proinsulin expression had any possible physiological implication and
tried to look at events in early development that may be modulated
by insulin or proinsulin.
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Abnormal levels of proinsulin/insulin signalling
cause changes in programmed cell death
Since classic binding-competition and autoradiography studies
had revealed that the chick embryo had insulin receptors and
IGF-I receptors from the stage of gastrulation onwards (1,18), we
suspected that the proteins of the family had previously unknown
roles in early development. We focused our attention on the process
of programmed cell death, generally occurring as apoptosis, which is
relevant to multiple morphogenetic events in development (43)
including the closure of the neural tube (Fig. 4A). Using the
technique of Terminal Deoxynucleotidyltransferase-mediated UTP
Nick End Labelling (TUNEL), we could quantify the number of cells
of a chick embryo during neurulation that undergo apoptosis, in
vivo and in culture (Fig. 4B, C). When the embryonic endogenous
proinsulin signal was interfered by using antisense oligonucleotides
against proinsulin mRNA (25) or the insulin receptor mRNA (19),
there was an increase in the number of cells dying of apoptosis
(Fig. 4). Preventing cell death, thus, appeared as an important
function of embryonic proinsulin. The modulation of the chaperone
heat shock cognate 70 by proinsulin/insulin was found to correlate
with the prevention of apoptosis (10).
We had known for some years that correct proinsulin/insulin
signalling was needed to continue normal development beyond
neurulation since insulin or insulin receptor antibodies caused a
certain level of malformed or dead embryos between E2 and E4 of
development (12). Opposite pharmacological experiments involving
the addition of excess insulin or proinsulin also caused abnormalities
and death (13).
In a similar way, it was found critical during neurulation to
maintain the proinsulin signal within physiological limits. An excess
of exogenously added proinsulin caused abnormalities that affected
the neuropore, neural tube, and optic vesicles in the neurulating
embryo (Table I), concomitant with a decrease in natural apoptosis
(42). A tightly regulated proinsulin gene expression, therefore, is
required to maintain the level of cell survival/cell death also strictly
regulated in the embryo. This suggests an early important role for a
protein prohormone previously thought to have little activity.
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FIGURE 4. Apoptotic cell death in the chick embryo dorsal neural tube. A) Cross-
section of the neural tube by scanning electron microscopy of a E1.5 embryo.
B) TUNEL assay detecting apoptotic cells, predominant in the dorsal part (upper) of
the neural tube. C) Dissociated cells from the embryo stained by TUNEL (note bright
apoptotic bodies). D) Mean values of percent of apoptotic cells in E1.5 embryos
treated with antisense oligonucleotides against the insulin receptor (IR oligo AS)
or a control (IR oligo CON).
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p y
Nº of embryos
Control embryos abnormal 0 /13
Proinsulin treated embryos abnormal             12/15
Abnormalities:
Asymmetric anterior neuropore closure       5/15
Flattened optic vesicles                                8/15
Asymmetric rhombomers                             6/15
Neural tube flexures                                    9/15
Reduction of apoptosis in proinsulin 
treated embryos:                                                5/5
From Hernández-Sánchez et al. 2003
TABLE I. Developmental abnormalities induced by proinsulin excess
in E1,5 chick embryos
IGF-I is essential for differentiation of neural stem/precursor
cells in mice
After the progress made in understanding an early developmental
role of proinsulin, it did not escape our attention that most
investigators in the field of growth and development had analysed
the possible roles of two other proteins of the family, IGF-I and II,
in much more depth. Experiments using gene targeting deletion
approaches generated mice lacking expression of IGF-I and II, and
their receptors, alone or in combination, over a decade ago. Together
with the confirmation of the essential role of each of these two
factors in prenatal growth -in addition to IGF-I’s role in postnatal
growth, which has led to its use in human therapy (35) emerged
evidence of a variety of subtle phenotypes in different tissues (3,
23, 27). From our previous studies in chick embryos we knew that
IGF-I was expressed earlier during organogenesis in the nervous
system than in other tissues; the availability of IGF-I knockout mice
convinced us to switch to this model for a detailed analysis of the
role of IGF-I in neurogenesis.
To set out a suitable system for manipulation we established
highly proliferative cultures with the self-renewal characteristics of
stem cells (39), obtained from the olfactory bulb of embryonic E12.5
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FIGURE 5. Isolation of neural stem cells from E15 mouse olfactory bulb (O.B.).
Mouse embryo O.B. are dissected from brain (line over the dorsal view indicates the
section plane) and dissociated cells are placed in culture in the presence of FGF-2 and
EGF plus insulin or IGF-I. The cells divide actively and after 3-4 days they form
round aggregates, denominated neurospheres. After multiple passages the cells main-
tain their proliferative nature. When the mitogens are withdrawn (in the presence of
insulin or IGF-I) and cells are plated at high density, they enter a differentiation
program and, after 3-5 days, cells with the characteristics of neurons (TUJ1+), astro-
cytes (GFAP+) and oligodendrocytes (O4+) can be identified in the culture. The percen-
tages indicated are the average values obtained in a typical culture (40).
to E14.5 mice (40) (Fig. 5). These cells, growing as neurospheres,
were stimulated to proliferate by exogenous IGF-I in a dose-
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dependent manner. Interestingly, insulin or proinsulin had no effect
on proliferation, and only a small cell survival effect if added alone,
but they were synergistic with EGF and FGF2 when added together
with these two mitogens. When high insulin or low IGF-I was present
and the mitogens were withdrawn, the stem cells stopped
proliferating and underwent differentiation into the three types of
cells characteristic of the central nervous system: neurons, astrocytes
and oligodendrocytes (Fig. 5). Compared to other types of embryo-
derived neural stem cells reported in the literature, the isolated
olfactory bulb stem/precursor cells showed a remarkable capacity to
generate neurons (52% of the differentiated cells after 3-4 days)
(Fig. 5).
If instead of preparing neurospheres from olfactory bulbs of wild
type mice, we used IGF-I knockout mice, the cells were able to
proliferate in culture normally, whereas their ability to differentiate
into neurons and glia were impaired (40). This finding agreed with
in vivo data, since olfactory bulb mitral neurons were decreased in
the IGF-I knockout embryos at E18.5 (32).
FIGURE 6. Expression of proinsulin II mRNA in the O.B. stem cells. A) RT-PCR
of a common region of proinsulin mRNA I and II followed by Southern blot with
a nested oligonucleotide in pancreas and proliferative neural stem cells (NSC).
B) Restriction enzyme digestion with MspI of the PCR products generated in A,
followed by Southern blot shows the presence of proinsulin II in NSC.
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The fact that the cells from mice lacking IGF-I managed to
maintain normal proliferation in culture suggested that perhaps they
were overproducing other proteins of the insulin family or they were
upregulating the IGF-I receptor to compensate. We set out RT-PCR
analysis of the proinsulin I and proinsulin II mRNAs from wild type
mice in a way that we could determine if one or both of the genes
were expressed. In the mouse pancreas, the two mRNAs are co-
expressed, whereas in the proliferating neural stem cells, only
proinsulin II mRNA was found (Fig. 6). Additional experiments
compared the wild type neural stem cells with those from IGF-I
knockout mice and the results were variable (Fig. 7). We would need
to analyze a larger number of mice to be certain that there was
overcompensation at the level of proinsulin II expression in the
absence of IGF-I. Even with similar amounts of proinsulin mRNA,
however, different transcripts with distinct translational capacity
might be present, an aspect that remains to be elucidated. More
FIGURE 7. Expression of proinsulin, IGF-II and IGF-I receptor in O.B. stem cells
from wild type (WT) and IGF-I knockout mice (KO). RNA from the proliferative O.B.
stem cells derived from normal mice or mice null for IGF-I was subjected to RT-PCR
followed by Southern blot for the indicated genes, proinsulin, IGF-II, the IGF-I recep-
tor and the control GAPDH (corresponding in each case to the sample(s) above.
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consistent results were observed with IGF-II and the IGF-I receptor
mRNAs, neither of which appeared to change in proliferating neural
stem cells under proliferative conditions, whether or not they had
the IGF-I gene knockout (Fig. 7). Nevertheless, this finding does not
exclude the possibility that IGF-II or the IGF-I receptor could be up-
regulated at the posttranscriptional level.
In neurogenesis, therefore, the presence of proinsulin as well as
IGF-I and II mRNAs suggests that all three proteins may play a role
but the most clear effect observed, thus far, is the essential action of
IGF-I in neural differentiation, at least in the mouse olfactory bulb.
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